Codeine

Codeine may cause serious or life-threatening breathing problems, especially during the first 24 to 72 hours of your treatment and any time your dose is increased.    ............................................

Codeine

Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Codeine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. it belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When it is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing.

Codeine is also available in combination with acetaminophen (Capital and Codeine, Tylenol with Codeine), aspirin, carisoprodol, and promethazine and as an ingredient in many cough and cold medications. This monograph only includes information about the use of it . If you are taking a codeine combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.

 

Codeine

Codeine: learn about side effects, dosage, special precautions, and more. Codeine is an opioid pain-relief medicine used for the short-term relief of mild to moderate pain. · It is not usually recommended for the treatment of chronic. part of a group of drugs known as opioids which interact with receptors in the brain and can elicit feelings of pain relief. it is a medication used in the management and treatment of chronic pain. It is in the opioid class of medications. it is a weak narcotic pain reliever and cough suppressant that is similar to morphine and hydrocodone. it is used to relieve mild to moderate pain. It belongs to the group of medicines called narcotic analgesics (pain medicines).Medscape – Antitussive, pain-specific dosing for, frequency-based adverse effects, comprehensive interactions, contraindications, Codeine is an opioid pain reliever used to treat mild to moderately severe pain. It is also used .

Buy Codeine

Codeine may be habit forming. Take codeine exactly as directed. Do not take more or less of it, take it more often, stop taking it suddenly, or take it in a different way than directed by your doctor. Tell your doctor if you or anyone in your family drinks or has ever drunk large amounts of alcohol, uses or has ever used street drugs, or has overused prescription medications, or has had an overdose, or if you have or have ever had depression or another mental illness.

Codeine may cause serious or life-threatening breathing problems, especially during the first 24 to 72 hours of your treatment and any time your dose is increased. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment: slowed breathing, long pauses between breaths, or shortness of breath.

Codeine may harm or cause death to other people who take your medication, especially children. Store codeine in a safe place so that no one else can take it accidentally or on purpose.

Taking certain medications, drinking alcohol, or using street drugs during your treatment with codeine may increase the risk that you will experience breathing problems or other serious, life-threatening breathing problems, sedation, or coma. Tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the dosages of your medications and will monitor you carefully.

Tell your doctor if you are pregnant or plan to become pregnant. If you take codeine regularly during your pregnancy, your baby may experience life-threatening withdrawal symptoms after birth.

Your doctor or pharmacist will give you the Medication Guide. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit https://www.fda.gov/Drugs/DrugSafety/ucm085729.htm to obtain the Medication Guide.

Talk to your doctor about the risks of taking codeine.

Why is this medication prescribed?

Codeine is used to relieve pain. It is also used to relieve cough. Codeine belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When codeine is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing.

Codeine is also available in combination with acetaminophen and aspirin, and as an ingredient in many cough and cold medications. This monograph only includes information about the use of codeine. If you are taking a codeine combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.

How should this medicine be used?

Codeine comes as an immediate-release tablet, an extended-release tablet, a solution (liquid), and syrup to take by mouth. Take every 4 hours as needed for pain. Take codeine solution or syrup every 4 to 6 hours as needed to relieve cough. Take codeine extended-release tablets every 12 hours as needed to relieve cough.

If you are taking codeine to relieve pain, your doctor may adjust your dose during your treatment, depending on how well your pain is controlled and on the side effects that you experience. Talk to your doctor about how you are feeling during your treatment with codeine. Tell your doctor if you feel that your pain is not controlled or if your pain increases, becomes worse, or if you have new pain or an increased sensitivity to pain during your treatment with codeine. Do not take more of it or take it more often than prescribed by your doctor.

Talk to your doctor or pharmacist about access to rescue medicines, naloxone or nalmefene, while taking codeine. Rescue medications can reverse the life-threatening effects of an opioid overdose and are available over the counter or with a prescription. Make sure that you and your family members and people usually around you know how to recognize an overdose, how to use naloxone or nalmefene, and what to do until emergency medical help arrives. Your doctor or pharmacist will show you and others how to use it. If symptoms of an overdose occur, they should give the first dose of naloxone, call 911 immediately, and stay with you and watch you closely until emergency medical help arrives. If your symptoms return, the person should give you another dose of the rescue medication. Additional doses may be given every 2 to 3 minutes, if symptoms return before medical help arrives.

If you have taken codeine for several weeks or longer, do not stop taking the medication without talking to your doctor. Your doctor may decrease your dose gradually. If you suddenly stop taking codeine, you may experience withdrawal symptoms such as restlessness, widened pupils (black circles in the center of the eyes), teary eyes, irritability, anxiety, runny nose, difficulty falling asleep or staying asleep, yawning, sweating, fast breathing, fast heartbeat, chills, hair on your arms standing on end, nausea, loss of appetite, vomiting, diarrhea, stomach cramps, muscle aches, or backache.

If you are taking codeine oral solution or syrup, do not use a household spoon to measure your dose. Use the measuring cup or spoon that came with the medication or use a spoon that is made especially for measuring medication. Ask your pharmacist if you have any question about how much medication you should take or how to use the dosing cup or syringe.

Other uses for this medicine

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

What special precautions should I follow?

Before taking codeine,

  • tell your doctor and pharmacist if you are allergic to codeine, any other medications, or any of the ingredients in the codeine product you plan to take. Ask your doctor or pharmacist for a list of the ingredients.
  • some medications should not be taken with codeine. Make sure you have discussed any medications you are currently taking or plan to take before starting codeine with your doctor and pharmacist. Before starting, stopping, or changing any medications while taking codeine, please get the advice of your doctor or pharmacist.
  • tell your doctor or pharmacist if you are taking the following medications or if you have stopped taking them within the past 2 weeks: isocarboxazid, linezolid, methylene blue, phenelzine, selegiline, or tranylcypromine.
  • the following nonprescription or herbal products may interact with codeine: St. John’s wort and tryptophan. Be sure to let your doctor and pharmacist know that you are taking these medications before you start taking codeine. Do not start these medications while taking codeine without discussing it with your healthcare provider.
  • tell your doctor if you have slowed breathing, asthma, chronic pulmonary disease (COPD), or other lung problems; a blockage or narrowing of your stomach or intestines, or paralytic ileus (condition in which digested food does not move through the intestines). Your doctor may tell you not to take codeine.
  • tell your doctor if you have or have ever had a brain tumor, or any condition that increases the amount of pressure in your brain; seizures; or thyroid, pancreatic, gallbladder, heart, liver, or kidney disease.
  • you should know that this medication may decrease fertility in men and women. Talk to your doctor about the risks of taking codeine.
  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking codeine, call your doctor.
  • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
  • you should know to not drink alcoholic beverages while you are taking codeine. Alcohol can make the side effects from codeine worse.
  • you should know that codeine may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking codeine. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.
  • you should know that codeine may cause constipation. Talk to your doctor about changing your diet and using other medications to treat or prevent constipation.

What special dietary instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What should I do if I forget a dose?

Codeine is usually taken as needed. If you miss a dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

What side effects can this medication cause?

Codeine may cause side effects. Tell your doctor if any of these symptoms or those in the SPECIAL PRECAUTIONS section are severe or do not go away:

  • nausea, vomiting
  • sweating
  • decreased sexual desire, inability to get or keep an erection

Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNINGS section, stop taking codeine and call your doctor immediately or get emergency medical attention:

  • agitation, hallucinations (seeing things or hearing voices that do not exist), fever, sweating, confusion, fast heartbeat, shivering, severe muscle stiffness or twitching, loss of coordination, nausea, vomiting, or diarrhea
  • nausea, vomiting, loss of appetite, weakness, or dizziness
  • chest pain, changes in heartbeat
  • rash; hives; itching; nausea; vomiting; hoarseness; difficulty breathing or swallowing; or swelling of the eyes, face, lips, mouth, tongue or throat
  • seizures
  • extreme drowsiness
  • new pain or pain from touch or doing ordinary tasks such as combing your hair
  • difficulty swallowing, regurgitation (bringing up swallowed food into throat and mouth), pain in the chest area
  • unusual snoring or long pauses during breaths during sleep

Codeine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online (https://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What should I know about storage and disposal of this medication?

Keep this medication in the container it came in, tightly closed, and out of reach of children, and in a location that is not easily accessible by others, including visitors to the home. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Keep all medication out of sight and reach of children as many containers are not child-resistant. Always lock safety caps. Place the medication in a safe location – one that is up and away and out of their sight and reach. https://www.upandaway.org

Dispose of unneeded medications in a way so that pets, children, and other people cannot take them. Do not flush this medication down the toilet. Use a medicine take-back program. Talk to your pharmacist about take-back programs in your community. Visit the FDA’s Safe Disposal of Medicines website https://goo.gl/c4Rm4p for more information.

In case of emergency/overdose

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can’t be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • difficulty breathing, slow or shallow breathing
  • unable to respond or wake up
  • limp or weak muscles
  • cold and clammy skin
  • increase or decrease in pupil (dark circle in the eye) size
  • slow heartbeat

What other information should I know?

Keep all appointments with your doctor.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking codeine.

Do not let anyone else use your medication, even if he or she has the same symptoms that you have. Selling or giving away this medication may cause death or harm to others and is illegal. Your prescription might not be refillable. Ask your pharmacist any questions you have about refilling your prescription.

Keep a written list of all of the prescription and nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital. You should carry the list with you in case of emergencies.

 

Brand names

  • Codeprex® (as a combination product containing Chlorpheniramine, Codeine)
  • Penntuss® (as a combination product containing Chlorpheniramine, Codeine)
  • Tuxarin ER® (as a combination product containing Chlorpheniramine, Codeine)
  • Tuzistra XR® (as a combination product containing Chlorpheniramine, Codeine)

Brand names of combination products

  • Ambenyl® (containing Bromodiphenhydramine, Codeine)
  • Bromanyl® (containing Bromodiphenhydramine, Codeine)
  • Bromotuss® with Codeine (containing Bromodiphenhydramine, Codeine)
  • Pherazine® VC with Codeine (containing Codeine, Phenylephrine, Promethazine)
  • Phenergan® VC with Codeine (containing Codeine, Phenylephrine, Promethazine)
  • Phenergan® with Codeine (containing Codeine, Promethazine)
  • Prometh VC® with Codeine (containing Codeine, Phenylephrine, Promethazine)

This branded product is no longer on the market. Generic alternatives may be available.

What is codeine?

Codeine is an opioid medicine that is only available with a prescription from your doctor.

LOOKING FOR A MEDICINE? — To search by brand name or active ingredient, use the Medicines information search feature.

How does codeine work?

Codeine works directly on the central nervous system and reduces feelings of pain by interrupting the way nerves signal pain between the brain and the body.

It also suppresses the activity centre in the brain that controls coughing.

What is codeine used for?

Codeine is used for short-term pain relief. It should only be used when other forms of non-opioid pain relief have not been successful in managing pain. When opioid medicine is required for pain relief, options other than codeine are often preferred because they offer more predictable effects and are generally safer for most people.

Some people will not experience pain relief from codeine because their bodies are unable to process the medicine. This is due to a genetic difference, which is more common in Caucasians.

Other people have a genetic difference that makes them process codeine faster — this can lead to higher doses of codeine being released quickly into the body, and an increased chance of overdose or side effects. This genetic difference is more common in North African and Middle Eastern communities.

Learn more about opioid medicines and pain

Codeine is not usually recommended for the treatment of chronic pain.

Codeine may also relieve a dry cough, although it is not generally recommended for this purpose.

In some situations, codeine can also relieve diarrhoea by reducing the motility (movement) of the intestines.

What forms of codeine are available?

Codeine is available in tablet form and as an oral liquid. Codeine is also available in a tablet formulation combined with other medicines, such as paracetamol, ibuprofen or aspirin.

What are the possible side effects of taking codeine?

All opioids, including codeine, can have side effects including life-threatening breathing problems. The chance of these side effects is higher:

  • when first taking codeine
  • after a dosage increase
  • if you are older
  • if you have an existing lung problem

The side effects of codeine are similar to those of other opioids, and include:

FIND A HEALTH SERVICE — The Service Finder can help you find doctors, pharmacies, hospitals and other health services.

What are the risks associated with taking codeine?

Opioids are strong pain medicines and can cause life-threatening breathing problems.

Codeine may make it difficult for you to drive or operate heavy machinery. If you have recently started taking an opioid medicine, or changed the dosage, you may be more likely to have an accident. Ask your doctor if it is safe and legal to drive while taking codeine. Also contact your car insurer, as you may not be covered for accidents that occur while you are taking codeine.

If your kidney or liver function is impaired, your doctor may decide that codeine is not appropriate for you. There are other factors that may limit your use of codeine — for example, if you drink alcohol or take other medicines such as benzodiazepines that can cause drowsiness.

Your doctor is the best person to advise you on whether codeine is the right medicine for you, how much you need and how long to take it for.

Opioid tolerance and dependence

If you use opioid medicines, you may also develop tolerance. This means that you may need to take larger amounts of the opioid to get the same effect. The chance of side effects also increases with a higher dose.

It’s possible to become dependent on this medicine even if you take it exactly as prescribed by your doctor. Your doctor will help monitor how you use codeine, to reduce your chance of harm, including through misuse, abuse and addiction.

If you are concerned that you are becoming addicted to or dependent on codeine let your doctor know so that you can get help. You can also call the National Alcohol and Other Drug Hotline (1800 250 015) for 24/7 support and treatment information.

WORRIED ABOUT YOUR OPIOID USE? — The Opioid Risk Indicator can help you find out if you may be developing a problem.

Opioid overdose

 

If a person is not breathing, if they are unresponsive, or if you are concerned about an overdose of codeine or any opioid-containing medicine, seek help straight away. Call triple zero (000) and ask for an ambulance.

If you take too much codeine (known as an overdose), it’s important to get immediate medical attention. Overdose of opioid medicines can cause you to stop breathing.

Symptoms of overdose include:

  • feeling sleepy
  • difficulty breathing
  • loss of consciousness
  • pinpoint (very small) pupils

Access to overdose-reversing medication

Naloxone is a medicine that can temporarily reverse the effects of an opioid overdose. The Australian Government is offering this medicine free of charge and without a prescription to people who may experience, or witness, an opioid overdose.

Learn more about the Take Home Naloxone program.

How do I take codeine?

Always take it exactly as your doctor has prescribed.

Your doctor may recommend a diet high in fibre or using laxatives while you take codeine to prevent opioid-induced constipation.

Continue to take codeine for as long as your doctor tells you to. If you stop taking codeine suddenly, you may experience withdrawal symptoms.

How do I dispose of medicines safely?

It’s important you dispose of unwanted opioid medicines safely. Unused medicines can be returned to any pharmacy. Don’t keep unused codeine ‘just in case’. This can lead to dangerous or inappropriate use.

Keep codeine out of reach of children and pets. Never throw medicines into a garbage bin or flush them down the toilet, as this is dangerous to others and harmful to the environment.

When should I see my doctor?

If your pain is not well controlled with codeine or you have any new, unexpected or unwanted side effects, see your doctor.

ASK YOUR DOCTOR — Preparing for an appointment? The Pain Question Planner can help you create a list of questions for your doctor.

Are there alternatives to codeine?

Everyone’s pain is unique, and different pain relief medicines will work in different circumstances. Some people’s pain will respond well to non-opioid medicines, which are generally associated with fewer problems and side effects.

Always check with your doctor or pharmacist before making any change to the dosage or type of medicine you take.

If you have chronic (long-term) pain, your doctor might suggest lifestyle changes to help manage the discomfort. This may include:

Read more on options for managing chronic pain.

If you are taking codeine to suppress your cough, there are other medicines available at a pharmacy. Talk to your doctor or pharmacist about suitable options.

Resources and support

See also this list of medicines that contain codeine and read the consumer information medicine (CMI) leaflet for the brand prescribed, or:

Information for Aboriginal and/or Torres Strait Islander peoples

  • Visit Positive Choices for an overview of drug services and resources for Aboriginal and/or Torres Strait Islander peoples and communities.
  • Your Room is a website with resources and information about drugs for Aboriginal and/or Torres Strait Islander peoples.
  • Learn more about pain management on Pain Management Network.

Learn more here about the development and quality assurance of healthdirect content.

 

codeine cough syrup

Drug interactions
Dosage information
During pregnancy or Breastfeeding
Reviews (57)
Drug images
Compare alternatives
Pricing & coupons
En español
Drug class: antitussives
Patient resources
Drug Information
Codeine Tablets
Codeine Oral Solution
Professional resources
Prescribing Information
Related treatment guides
Cough
Pain
Diarrhea

codeine phosphate

. Revised 03/2024. West-Ward Pharmaceuticals Corp. 
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use codeine only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. May not be suitable for some people including children of any age who have undergone a tonsillectomy or adenoidectomy, people with pre-existing respiratory depression or respiratory disease, with seizure disorders or a head injury, people with gastrointestinal obstruction, or recent use of monoamine oxidase inhibitors.
Should not be used during pregnancy or breastfeeding unless specifically recommended and monitored by a doctor. Can cause life-threatening withdrawal symptoms in a newborn.

Nearly $150,000 worth of codeine was seized near Tucson on Monday.

codeine phosphate 30mg دواء

Codeine is addictive (habit-forming) and potentially abusable. should only be used short-term at the lowest effective dose and only when other nonopioid analgesics are not effective. Tolerance can also develop to  analgesic effect (this means that the same dose does not provide as much pain relief as before). Legitimate supplies of products containing codeine may be sought out by drug seekers.
Abrupt discontinuation of the bottle in a person who has become physically dependent on it may lead to a withdrawal syndrome and symptoms such as restlessness, pupil dilation, watery eyes and a runny nose, sweating, muscle aches, insomnia, irritability and gastrointestinal complaints.

Rarely, serious, life-threatening, breathing problems may occur attributable to the component. The risk is greater with higher dosages of it, in people with pre-existing respiratory disease, in seniors or the frail, or in those taking other medications that cause respiratory depression (such as benzodiazepines). Not for use in children under the age of 18.
it may interact with several drugs, including those that affect hepatic enzymes CYP 3A4 or CYP 2D6, and those that also cause respiratory depression (such as other opioids, benzodiazepines, and alcohol).
Interaction or overdosage may also cause serotonin syndrome. Symptoms include mental status changes such as agitation, hallucinations, coma, or delirium; a fast heart rate; dizziness; flushing; muscle tremor or rigidity; and stomach symptoms (including nausea, vomiting, and diarrhea).
Long-term use of cough medicine also affects the endocrine system, which may cause symptoms such as sexual dysfunction, an absence of periods, or infertility.

codeine 30mg

Codeine is an opiate and prodrug of morphine used to treat pain, coughing, and diarrhea.It is found naturally in the sap of the opium poppy, Papaver somniferum. It is typically used to treat mild to moderate degrees of pain. 

Drowsiness or dizziness which may impair reaction skills and affect a person’s ability to drive or operate machinery. Avoid alcohol.
also slows down the motility of the gastrointestinal tract. This can lead to symptoms such as nausea, vomiting, constipation, and abdominal pain. Laxatives may be required.
may also affect blood pressure, manifesting as dizziness when standing; and stimulate histamine release, which may cause symptoms such as flushing, itchiness, sweating, or red eyes.

Babies born to mothers who are physically dependent on it will also be physically dependent.
Marked differences may exist in the analgesic effect provided by due to genetic variations in the CYP 2D6 liver enzyme responsible for metabolizing into morphine. Consider alternative analgesics if codeine is not having the desired pain-relieving effect.

codeine cough syrup
Rated 5 out of 5
Steve Hard
Steve Hard@steve
Read More
Best supplier
jennifer lum
jennifer lum@jennefer2
Read More
Great customer service and fast shipping
joe brandy
joe brandy@brandy23
Read More
Fast and reliable
kif hindermaan
kif hindermaan@kif234
Read More
Special drinks always available and am happy to be your regular
Previous
Next
codeine linctus

Note that this list is not all-inclusive and includes only common medications that may interact with it. You should refer to the prescribing information for it for a complete list of interactions.

codeine comprimé

Do not double up on other medications containing it (several cold and flu remedies also contain this ).
Avoid alcohol while taking . Alcohol can contribute to the sedative effects of and also increase the risk of respiratory depression.
may make you feel dizzy when getting up from a lying down or sitting position to standing. Always get up slowly, but talk with your doctor if this dizziness results in a fall.
Codeine may cause constipation which can be relieved with laxatives. Drink 6 to 8 full glasses of water daily to prevent this effect. Talk to your doctor if you experience any troublesome side effects of before using a laxative..
Seek urgent medical advice if you experience any excessive sedation, breathing difficulties, wheezing, rash, itching, or facial swelling. Call emergency services if you suspect somebody has overdosed on (pinpoint pupils may be indicative of overdosage).
Do not use during pregnancy or breastfeeding unless specifically recommended by your doctor.
Keep this medicine in a safe place and out of the reach of children and pets. Accidental ingestion can result in a fatal overdose of it , especially in children. Never give it to children under the age of 18.

Codeine

Codeine, an opioid analgesic, was originally approved in the US in 1950 and is a drug used to decrease pain by increasing the threshold for pain. Codeine may cause serious or life-threatening breathing problems, especially during the first 24 to 72 hours of your treatment . It is a medication used in the management and treatment of chronic pain. It is in the opioid class of medications. This is an oral prescription opioid (narcotic) drug most commonly used to treat mild-to-moderate pain, as a cough suppressant . is an opioid pain-relief medicine used for the short-term relief of mild to moderate pain. · It is not usually recommended for the treatment of chronic . 

IMPORTANT WARNING:

Codeine may be habit forming. Take it exactly as directed. Do not take more of it, take it more often, or take it in a different way than directed by your doctor. While taking codeine, discuss with your healthcare provider your pain treatment goals, length of treatment, and other ways to manage your pain. Tell your doctor if you or anyone in your family drinks or has ever drunk large amounts of alcohol, uses or has ever used street drugs, or has overused prescription medications, or has had an overdose, or if you have or have ever had depression or another mental illness. There is a greater risk that you will overuse . if you have or have ever had any of these conditions. Talk to your healthcare provider immediately and ask for guidance if you think that you have an opioid addiction or call the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-HELP.

Codeine may cause serious or life-threatening breathing problems, especially during the first 24 to 72 hours of your treatment and any time your dose is increased. Your doctor will monitor you carefully during your treatment. Tell your doctor if you have or have ever had slowed breathing or asthma. Your doctor will probably tell you not to take codeine. Also tell your doctor if you have or have ever had lung disease such as chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways), a head injury, brain tumor, or any condition that increases the amount of pressure in your brain. The risk that you will develop breathing problems may be higher if you are an older adult or are weak or malnourished due to disease. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment: slowed breathing, long pauses between breaths, or shortness of breath.

When it was used in children, serious and life-threatening breathing problems such as slow or difficulty breathing and deaths were reported. Codeine should never be used to treat pain or a cough in children younger than 18 years of age. If your child is currently prescribed a cough and cold medicine containing it , talk to your child’s doctor about other treatments.

Taking certain medications during your treatment with it may increase the risk that you will experience breathing problems or other serious, life-threatening breathing problems, sedation, or coma. Tell your doctor if you are taking or plan to take any of the following medications: certain antibiotics such as erythromycin (Erytab, Erythrocin); certain antifungal medications including ketoconazole; benzodiazepines such as alprazolam (Xanax), diazepam (Diastat, Valium), estazolam, flurazepam, lorazepam (Ativan), and triazolam (Halcion); carbamazepine (Carbatrol, Epitol, Equetro, Tegretol, Teril); certain medications for human immunodeficiency virus (HIV) including indinavir (Crixivan), nelfinavir (Viracept), and ritonavir (Norvir, in Kaletra); medications for mental illness or nausea; other medications for pain; muscle relaxants; phenytoin (Dilantin, Phenytek); rifampin (Rifadin, Rimactane, in Rifamate); sedatives; sleeping pills; or tranquilizers. Your doctor may need to change the dosages of your medications and will monitor you carefully. If you take codeine with any of these medications and you develop any of the following symptoms, call your doctor immediately or seek emergency medical care: unusual dizziness, lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness. Be sure that your caregiver or family members know which symptoms may be serious so they can call the doctor or emergency medical care if you are unable to seek treatment on your own.

Drinking alcohol or using street drugs during your treatment is also increases the risk that you will experience these serious, life-threatening side effects. Do not drink alcohol, take prescription or nonprescription medications that contain alcohol, or use street drugs during your treatment.

Tell your doctor if you are pregnant or plan to become pregnant. If you take its regularly during your pregnancy, your baby may experience life-threatening withdrawal symptoms after birth. Tell your baby’s doctor right away if your baby experiences any of the following symptoms: irritability, hyperactivity, abnormal sleep, high-pitched cry, uncontrollable shaking of a part of the body, vomiting, diarrhea, or failure to gain weight.

Do not allow anyone else to take your medication. it may harm or cause death to other people who take your medication, especially children.

Your doctor or pharmacist will give you the manufacturer’s patient information sheet (Medication Guide) when you begin treatment with it and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer’s website to obtain the Medication Guide.

Why is this medication prescribed?

Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Codeine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. it belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When codeine is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing.

Codeine is also available in combination with acetaminophen (Capital and Codeine, Tylenol with Codeine), aspirin, carisoprodol, and promethazine and as an ingredient in many cough and cold medications. This monograph only includes information about the use of it . If you are taking a combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.

How should this medicine be used?

Codeine (alone or in combination with other medications) comes as a tablet, a capsule, and a solution (liquid) to take by mouth. It is usually taken every 4 to 6 hours as needed. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take codeine exactly as directed.

If you have taken codeine for several weeks or longer, do not stop taking the medication without talking to your doctor. Your doctor may decrease your dose gradually. If you suddenly stop taking it , you may experience withdrawal symptoms such as restlessness, widened pupils (black circles in the center of the eyes), teary eyes, irritability, anxiety, runny nose, difficulty falling asleep or staying asleep, yawning, sweating, fast breathing, fast heartbeat, chills, hair on your arms standing on end, nausea, loss of appetite, vomiting, diarrhea, stomach cramps, muscle aches, or backache.

Shake the solution well before each use to mix the medication evenly. Do not use a household spoon to measure your dose. Use the measuring cup or spoon that came with the medication or use a spoon that is made especially for measuring medication.

Other uses for this medicine

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

What special precautions should I follow?

Before taking codeine,

  • tell your doctor and pharmacist if you are allergic to it , any other medications, or any of the ingredients in the product you plan to take. Ask your doctor or pharmacist for a list of the ingredients.
  • tell your doctor or pharmacist if you are taking or receiving the following monoamine oxidase (MAO) inhibitors or if you have stopped taking them within the past 2 weeks: isocarboxazid (Marplan), linezolid (Zyvox), methylene blue, phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate). Your doctor will probably tell you not to take it. if you are taking one or more of these medications, or have taken them within the past 2 weeks.
  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: bupropion (Aplenzin, Wellbutrin, Zyban); cyclobenzaprine (Amrix); diuretics (‘water pills’); lithium (Lithobid); medications for cough, cold, or allergies; medications for anxiety or seizures; medications for migraine headaches such as almotriptan (Axert), eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), rizatriptan (Maxalt), sumatriptan (Imitrex, in Treximet), and zolmitriptan (Zomig); mirtazapine (Remeron); 5HT3serotonin blockers such as alosetron (Lotronex), dolasetron (Anzemet), granisetron (Kytril), ondansetron (Zofran, Zuplenz), or palonosetron (Aloxi); selective serotonin-reuptake inhibitors such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, in Symbyax), fluvoxamine (Luvox), paroxetine (Brisdelle, Prozac, Pexeva), and sertraline (Zoloft); serotonin and norepinephrine reuptake inhibitors such as duloxetine (Cymbalta), desvenlafaxine (Khedezla, Pristiq), milnacipran (Savella), and venlafaxine (Effexor); tramadol (Conzip); trazodone (Oleptro); and tricyclic antidepressants (‘mood elevators’) such as amitriptyline, clomipramine (Anafranil), desipramine (Norpramin), doxepin (Silenor), imipramine (Tofranil), nortriptyline (Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil). Many other medications may also interact with codeine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor what herbal products you are taking, especially St. John’s wort and tryptophan.
  • tell your doctor if you have any of the conditions mentioned in the IMPORTANT WARNING section, a blockage or narrowing of your stomach or intestines, or paralytic ileus (condition in which digested food does not move through the intestines). Your doctor may tell you not to take it .
  • tell your doctor if you drink or have had recent abdominal or urinary tract surgery. Also tell your doctor if you have or have ever had seizures; mental illness; prostatic hypertrophy (enlargement of a male reproductive gland); urinary problems; low blood pressure; Addison’s disease (condition in which the body does not make enough of certain natural substances); or thyroid, pancreatic, intestinal, gallbladder, liver, or kidney disease.
  • you should know that this medication may decrease fertility in men and women. Talk to your doctor about the risks of taking codeine.
  • tell your doctor if you are breastfeeding. You should not breastfeed while taking codeine. Codeine can cause shallow breathing, difficulty or noisy breathing, confusion, more than usual sleepiness, trouble breastfeeding, or limpness in breastfed infants.
  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking it .
  • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
  • you should know that may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.
  • you should know that it may cause constipation. Talk to your doctor about changing your diet and using other medications to treat or prevent constipation.

What special dietary instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What should I do if I forget a dose?

Codeine is usually taken as needed. If your doctor has told you to take it regularly, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

What side effects can this medication cause?

Codeine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • headache
  • stomach pain
  • difficulty urinating

Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNINGS section, stop taking it and call your doctor immediately or get emergency medical attention:

  • agitation, hallucinations (seeing things or hearing voices that do not exist), fever, sweating, confusion, fast heartbeat, shivering, severe muscle stiffness or twitching, loss of coordination, nausea, vomiting, or diarrhea
  • nausea, vomiting, loss of appetite, weakness, or dizziness
  • inability to get or keep an erection
  • irregular menstruation
  • decreased sexual desire
  • noisy or shallow breathing
  • difficulty breathing or swallowing
  • changes in heartbeat
  • rash
  • itching
  • hives
  • changes in vision
  • seizures

Codeine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What should I know about storage and disposal of this medication?

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA’s Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of emergency/overdose

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can’t be awakened, immediately call emergency services at 911.

While taking it , you should talk to your doctor about having a rescue medication called naloxone readily available (e.g., home, office). Naloxone is used to reverse the life-threatening effects of an overdose. It works by blocking the effects of opiates to relieve dangerous symptoms caused by high levels of opiates in the blood. Your doctor may also prescribe you naloxone if you are living in a household where there are small children or someone who has abused street or prescription drugs. You should make sure that you and your family members, caregivers, or the people who spend time with you know how to recognize an overdose, how to use naloxone, and what to do until emergency medical help arrives. Your doctor or pharmacist will show you and your family members how to use the medication. Ask your pharmacist for the instructions or visit the manufacturer’s website to get the instructions. If symptoms of an overdose occur, a friend or family member should give the first dose of naloxone, call 911 immediately, and stay with you and watch you closely until emergency medical help arrives. Your symptoms may return within a few minutes after you receive naloxone. If your symptoms return, the person should give you another dose of naloxone. Additional doses may be given every 2 to 3 minutes, if symptoms return before medical help arrives.

Symptoms of overdose may include the following:

  • difficulty breathing
  • slow or shallow breathing
  • excessive drowsiness or sleepiness
  • unable to respond or wake up
  • loss of muscle tone
  • cold and clammy skin
  • fainting
  • dizziness
  • slow heartbeat

What other information should I know?

Keep all appointments with your doctor and laboratory. Your doctor will order certain lab tests to check your body’s response .

Before having any laboratory test (especially those that involve methylene blue), tell your doctor and the laboratory personnel that you are taking codeine.

Selling or giving away this medication may cause death or harm to others and is illegal. Your prescription might not be refillable. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Brand names

  • Tuzistra XR® (as a combination product containing Chlorpheniramine, Codeine)

Brand names of combination products

  • Airacof® (containing Codeine, Diphenhydramine, Phenylephrine)
  • Ala-Hist AC® (containing Codeine, Phenylephrine)
  • Allfen CD® (containing Codeine, Guaifenesin)
  • Ambenyl® (containing Bromodiphenhydramine, Codeine)
  • Ambophen® (containing Bromodiphenhydramine, Codeine)
  • Antituss AC® (containing Codeine, Guaifenesin)
  • Bitex® (containing Codeine, Guaifenesin)
  • Bromanyl® (containing Bromodiphenhydramine, Codeine)
  • Bromotuss® with Codeine (containing Bromodiphenhydramine, Codeine)
  • Brontex® (containing Codeine, Guaifenesin)
  • Bron-Tuss® (containing Codeine, Guaifenesin)
  • Brovex CB® (containing Brompheniramine, Codeine)
  • Brovex PBC® (containing Brompheniramine, Codeine, Phenylephrine)
  • Calcidrine® (containing Anhydrous Calcium Iodide, Codeine)
  • Cheracol® with Codeine (containing Codeine, Guaifenesin)
  • Cheratussin® (containing it , Guaifenesin)
  • Codafen® (containingit , Guaifenesin)
  • Codimal PH® (containing it , Phenylephrine, Pyrilamine)
  • Cotab A® (containing Chlorpheniramine, Codeine)
  • Demi-Cof® (containing Chlorpheniramine, Codeine, Phenylephrine, Potassium Iodide)
  • Dex-Tuss® (containing Codeine, Guaifenesin)
  • Diabetic Tussin C® (containing Codeine, Guaifenesin)
  • Dicomal-PH® (containing Codeine, Phenylephrine, Pyrilamine)
  • Duraganidin NR® (containing Codeine, Guaifenesin)
  • EndaCof AC® (containing Brompheniramine, Codeine)
  • Endal CD® (containing Codeine, Diphenhydramine, Phenylephrine)
  • ExeClear-C® (containing Codeine, Guaifenesin)
  • Gani-Tuss NR® (containing Codeine, Guaifenesin)
  • Giltuss Ped-C® (containing Codeine, Guaifenesin, Phenylephrine)
  • Glydeine® (containing Codeine, Guaifenesin)
  • Guaifen AC® (containing Codeine, Guaifenesin)
  • Guiatuss AC® (containing Codeine, Guaifenesin)
  • Guiatussin® with Codeine, Guaifenesin)
  • Halotussin AC® (containing Codeine, Guaifenesin)
  • Iophen® (containing Codeine, Guaifenesin)
  • Mar-cof CG® (containing Codeine, Guaifenesin)
  • Maxiphen CD® (containing Codeine, Guaifenesin, Phenylephrine)
  • M-Clear WC® (containing Codeine, Guaifenesin)
  • M-End PE® (containing Brompheniramine, Codeine, Phenylephrine)
  • Mytussin AC® (containing Codeine, Guaifenesin)
  • Nalex® AC (containing Brompheniramine, Codeine)
  • Notuss AC® (containing Chlorpheniramine, Codeine)
  • Notuss PE® (containing Codeine, Phenylephrine)
  • Pediacof® (containing Chlorpheniramine, Codeine, Phenylephrine, Potassium Iodide)
  • Pedituss® (containing Chlorpheniramine, Codeine, Phenylephrine, Potassium Iodide)
  • Pentazine VC® (containing Codeine, Phenylephrine, Promethazine)
  • Pentazine® with Codeine (containing Codeine, Promethazine)
  • Phenergan® VC with Codeine (containing Codeine, Phenylephrine, Promethazine)
  • Phenergan® with Codeine (containing Codeine, Promethazine)
  • Poly-Tussin AC® (containing Brompheniramine, Codeine, Phenylephrine)
  • Prometh® with Codeine (containing Codeine, Guaifenesin, Promethazine)
  • Robafen AC® (containing Codeine, Guaifenesin)
  • Robichem AC® (containing Codeine, Guaifenesin)
  • Robitussin® AC (containing Codeine, Guaifenesin)
  • Rolatuss® (containing Ammonium Chloride, Chlorpheniramine, Codeine, Phenylephrine)
  • Romilar AC® (containing Codeine, Guaifenesin)
  • Tusnel C® (containing Brompheniramine, Codeine, Guaifenesin)
  • Tussi Organidin® (containing Codeine, Guaifenesin)
  • Tussiden C® ( Guaifenesin)
  • Tussirex® (containing Caffeine, Codeine, Pheniramine, Phenylephrine, Salicylic Acid)
  • Tusso-C® (containing Codeine, Guaifenesin)
  • Vanacof® (containing Codeine, Dexchlorpheniramine, Phenylephrine)
  • Z Tuss AC® (containing Chlorpheniramine, Codeine)
  • Zodryl AC® (containing Chlorpheniramine, Codeine)
  • Zotex C® (containing Codeine, Phenylephrine, Pyrilamine)

This branded product is no longer on the market. Generic alternatives may be available.

1. How it works
Codeine is an opioid analgesic (pain-reliever) that is related to morphine.
Codeine works by weakly binding to a specific opioid receptor, known as the mu-opioid receptor, but with much less affinity than morphine, which means its analgesic (pain-relieving effects) are much less.
Codeine belongs to the group of drugs known as opioids or opioid analgesics. Codeine may also be called a narcotic analgesic.
2. Upsides
May be used to treat mild-to-moderate pain that is unrelieved by nonopioid analgesics.
Generic codeine is available.
3. Downsides
If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:

how long does lean stay in your system

Note: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. View complete list of side effects

4. Bottom Line
Codeine is an effective pain-reliever; however, it is addictive, may cause constipation, and its pain-relieving effects vary markedly between individuals. should only be used for pain relief when other simpler analgesics, such as acetaminophen or ibuprofen, are not appropriate.
5. Tips
May be taken with or without food. Do not take more than you have been prescribed. Codeine should be used short-term only. Long-term use may lead to addiction and dependence. may need to be discontinued slowly depending on the duration of use. Talk to your doctor about a tapering schedule. Never share your it with anyone. Do not keep your leftover medicine. Ask your pharmacy when the next take-back program is.
May cause sedation and affect your ability to drive or operate machinery. Do not drive or perform other hazardous tasks if it affects you in this way.
Use short-term (three days or less) only. Not recommended for long-term use.
Tell your doctor if you think you have become addicted to it or the usual dosage does not appear to be working.

6. Response and effectiveness
The analgesic effect of reaches a peak in about two hours and the effects last for between four to six hours.
About 70-80% of a dose of it is metabolized by the liver into a number of metabolites, some active and some inactive. One of these active metabolites is morphine. About 5-10% of it is metabolized into morphine by the hepatic enzyme, CYP2D6. Experts believe some of the analgesic properties of it are due to it being converted into morphine. Note that up to 10% of Caucasians, 6% of Mexican-Americans, and 5% of African-Americans are poor metabolizers at CYP2D6 and are unlikely to metabolize codeine into morphine. 30% of Ethiopians, 20% of Saudis, 10% of Portuguese and Greeks, and 4% of North Americans are ultra-rapid metabolizers at CYP 2D6 and may experience excessive side effects, such as extreme sleepiness, confusion, and shallow breathing, even with normal dosages of it
7. Interactions
Medicines that interact with may either decrease its effect, affect how long it works for, increase side effects, or have less of an effect when taken with it . An interaction between two medications does not always mean that you must stop taking one of the medications; however, sometimes it does. Speak to your doctor about how drug interactions should be managed.

Common medications that may interact :

antibiotics, such as erythromycin
antidepressants, such as tricyclic antidepressants (eg, amitriptyline), monoamine oxidase inhibitors (eg, isocarboxazid, phenelzine, and tranylcypromine), or SSRIs (eg, fluoxetine, sertraline)
antifungal agents, such as itraconazole and ketoconazole
anticonvulsants, such as carbamazepine, lamotrigine, phenytoin, phenobarbital, or primidone
antimigraine agents such as sumatriptan
antipsychotics (such as butyrophenones, phenothiazines, or thioxanthenes) and atypical antipsychotics (eg, olanzapine, quetiapine, ziprasidone)
any medication that may cause drowsiness, such as amphetamines, azelastine, benzodiazepines (eg, diazepam, lorazepam), first-generation antihistamines (such as doxylamine or promethazine), metoclopramide, or opioids (such as hydrocodone, morphine)
buprenorphine
HIV medications such as darunavir or ritonavir
muscle relaxants, such as cyclobenzaprine
naltrexone
other medications that are CYP2D6 or CYP3A4 inhibitors or inducers
pentazocine
rifampin.
Avoid drinking alcohol or taking illegal or recreational drugs while taking codeine.

.............................................................................................................................................................................................................................................................................................................................

Identification

Summary

Codeine is an opioid analgesic used to treat moderate to severe pain when the use of an opioid is indicated.

Brand Names
Ascomp, Cheratussin, Cheratussin Dac, Codar Ar, Codar D, Codar Gf, Codeine Contin, Covan, Damylin With Codeine, Fioricet With Codeine, Histex Ac, Linctus Codeine Blanc, M-clear Wc, M-end PE, Mar-cof BP, Mar-cof Cg, Mersyndol, Ninjacof Xg, Pseudodine C, Robaxacet-8, Robaxisal, Triacin-C, Trianal C, Triatec, Triatec-30, Triatec-8, Tusnel C, Tuxarin, Tuzistra, Tylenol With Codeine
Generic NameCodeine
DrugBank Accession NumberDB00318
Background

The relief of pain (analgesia) is a primary goal for enhancing the quality of life of patients and for increasing the ability of patients to engage in day to day activities. Codeine, an opioid analgesic, was originally approved in the US in 1950 and is a drug used to decrease pain by increasing the threshold for pain without impairing consciousness or altering other sensory functions. Opiates such as codeine are derived from the poppy plant, Papaver somniferum (Papaveraceae).4

Codeine is utilized as a central analgesic, sedative, hypnotic, antinociceptive, and antiperistaltic agent, and is also recommended in certain diseases with incessant coughing.Label,4

ModalitySmall Molecule
GroupsApproved, Illicit, Investigational
Structure
WeightAverage: 299.3642
Monoisotopic: 299.152143543
Chemical FormulaC18H21NO3
Synonyms
  • Codein
     
  • Codeína
     
  • Codéine
     
  • Codeine polistirex
  • Codeinum
  • Methylmorphine
External IDs 
 
  • IDS-NC-005(SECT.-2)

Pharmacology

The AI Assistant built for biopharma intelligence.
Access detailed, actionable insights to your most complex research questions. Leverage validated reasoning and citable data to power your critical research decisions.
Indication

Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label.

The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above 1415.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
 
Associated Conditions
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
 
Pharmacodynamics

General effects

Codeine is a weak narcotic pain reliever and cough suppressant that is similar to morphine and hydrocodone. A small amount of ingested codeine is converted to morphine in the body. Codeine increases tolerance to pain, reducing existing discomfort. In addition to decreasing pain, codeine also causes sedation, drowsiness, and respiratory depression 4.

Antitussive activity

This drug has shown antitussive activity in clinical trials 6 and has been effective in cough secondary to tuberculosis and insomnia due to coughing 4. Codeine suppresses the cough reflex through a direct effect on the cough center in the medulla 18.

Effects on intestinal motility

Codeine may reduce intestinal motility through both a local and possibly central mechanism of action 19. This may possibly lead to constipation 18. The chronic use of opioids, including codeine sulfate, may lead to obstructive bowel disease, particularly in patients with underlying disorders of intestinal motility Label.

Effects on the central nervous system

Codeine phosphate is an opioid analgesic with uses similar to those of morphine, but is much less potent as an analgesic. Its primary site of action is at the mu opioid receptors distributed throughout the central nervous system. The sedative activities of codeine are less potent than those of morphine 18. Codeine may cause respiratory system depression by the activation of μ-opioid receptors at specific sites in the central nervous system 8.

Effects on blood pressure

This drug poses an increased risk of compromised ability to maintain blood pressure due to peripheral vasodilation and other mechanisms Label.

Effects on chronic cancer pain and other types of pain

Codeine is an opioid analgesic with similar indications to those of morphine, however, is much less potent in its pain alleviating properties. Its primary action takes place at the mu opioid receptors, which are distributed throughout the central nervous system. The average duration of action is about 4 hours 18.

Regular dosing of opioid analgesics such as codeine in patients with severe cancer pain has been well documented to improve symptoms 47.

Mechanism of action

Although the exact mechanism of action of codeine is still unknown, it is generally thought to be mediated through the agonism of opioid receptors, particularly the mu-opioid receptors.4 Morphine was previously postulated to contribute to the analgesic effect of codeine due to the O-demethylation of codeine to morphine by CYP2D6. Particularly, CYP2D6 poor metabolizer did not experience the analgesic effect of codeine.2,10 However, this is unlikely to be the main mechanism of action of codeine as only 5% of codeine is metabolized to morphine.2 Other hypotheses also postulate that codeine-6-glucuronide, the main metabolite of codeine, mediates the analgesic effect of codeine as it not only has an affinity to the mu receptors as codeine but also can be metabolized to morphine-6-glucuronide, which was observed to be more potent than morphine.3

Binding to the mu receptors by codeine activates the G-proteins Gαi, causing a decrease in intracellular cAMP and Ca2+ level.11,12 This causes hyperpolarization of nociceptive neurons, thus imparing the transmission of pain signals.11,12

TargetActionsOrganism
AMu-type opioid receptor
agonist
regulator
Humans
AKappa-type opioid receptor
agonist
Humans
ADelta-type opioid receptor
agonist
Humans
Absorption

Absorption

Codeine is absorbed from the gastrointestinal tract. The maximum plasma concentration occurs 60 minutes after administration Label.

Food Effects

When 60 mg codeine sulfate was given 30 minutes post-ingestion of a high high-calorie meal, there was no significant change in the absorption of codeine Label.

Steady-state concentration

The administration of 15 mg codeine sulfate every 4 hours for 5 days lead to steady-state concentrations of codeine, morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) within 48 hours Label.

Volume of distribution

Apparent volume of distribution: about 3-6 L/kg, showing an extensive distribution of the drug into tissues Label.

Protein binding

7-25% bound to plasma proteins Label.

Metabolism

Approximately 70 to 80% of the ingested dose of codeine is metabolized in the liver by conjugation with glucuronic acid to codeine-6­ glucuronide (C6G) and by O-demethylation to morphine (about 5-10%) and N-demethylation to norcodeine (about 10%) respectively. UDP-glucuronosyltransferase (UGT) 2B7 and 2B4 are the major metabolic enzymes mediating the glucurodination of codeine to the metabolite, codeine 6 glucuronide.

Cytochrome P450 2D6 is the major enzyme responsible for the transformation of codeine to morphine and P450 3A4 is the main enzyme mediating the conversion of codeine to norcodeine. Morphine and norcodeine are then further metabolized by conjugation with glucuronic acid. The glucuronide metabolites of morphine are morphine-3-glucuronide (M3G) and_ morphine-6-glucuronide _(M6G). Morphine and M6G have been proven to have analgesic activity in humans. The analgesic activity of C6G in humans is not known at this time. Norcodeine and M3G are generally not considered to have analgesic properties Label.

Hover over products below to view reaction partners

Route of elimination

About 90% of the total dose of codeine is excreted by the kidneys. Approximately 10% of the drug excreted by the kidneys is unchanged codeine Label.

The majority of the excretion products can be found in the urine within 6 hours of ingestion, and 40-60 % of the codeine is excreted free or conjugated, approximately 5 to 15 percent as free and conjugated morphine, and approximately 10-20% free and conjugated norcodeine 18.

Half-life

Plasma half-lives of codeine and its metabolites have been reported to be approximately 3 hours Label.

Clearance

Renal clearance of codeine was 183 +/- 59 ml min-1 in a clinical study 5.

Renal impairment may decrease codeine clearance Label.

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
 
Toxicity

Oral LD50: 427 mg kg-1 (rat) MSDS.

Overdose/toxicity

Symptoms of opioid toxicity may include confusion, somnolence, shallow breathing, constricted pupils, nausea, vomiting, constipation and a lack of appetite. In severe cases, symptoms of circulatory and respiratory depression may ensue, which may be life-threatening or fatal 13Label.

Teratogenic effects

This drug is classified as a pregnancy Category C drug. There are no adequate and well-controlled studies completed in pregnant women. Codeine should only be used during pregnancy if the potential benefit outweighs the potential risk of the drug to the fetus Label.

Codeine has shown embryolethal and fetotoxic effects in the hamster, rat as well as mouse models at about 2-4 times the maximum recommended human dose Label. Maternally toxic doses that were about 7 times the maximum recommended human dose of 360 mg/day, were associated with evidence of bone resorption and incomplete bone ossification. Codeine did not demonstrate evidence of embrytoxicity or fetotoxicity in the rabbit model at doses up to 2 times the maximum recommended human dose of 360 mg/day based on a body surface area comparison Label.

Nonteratogenic effects

Neonatal codeine withdrawal has been observed in infants born to addicted and non-addicted mothers who ingested codeine-containing medications in the days before delivery. Common symptoms of narcotic withdrawal include irritability, excessive crying, tremors, hyperreflexia, seizures, fever, vomiting, diarrhea, and poor feeding. These signs may be observed shortly following birth and may require specific treatment Label.

Codeine (30 mg/kg) given subcutaneously to pregnant rats during gestation and for 25 days after delivery increased the rate of neonatal mortality at birth. The dose given was 0.8 times the maximum recommended human dose of 360 mg/day Label.

The use in breastfeeding/nursing

Codeine is secreted into human milk. The maternal use of codeine can potentially lead to serious adverse reactions, including death, in nursing infants Label.

Pathways
PathwayCategory
Codeine Action PathwayDrug action
Codeine Metabolism PathwayDrug metabolism
Codeine Opioid Action PathwayDrug action
Glutethimide Action PathwayDrug action
Pharmacogenomic Effects/ADRs 
 

Interactions

The AI Assistant built for biopharma intelligence.
Access detailed, actionable insights to your most complex research questions. Leverage validated reasoning and citable data to power your critical research decisions.
Drug Interactions 
 
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Food Interactions
  • Avoid alcohol.
  • Take with food. Food reduces irritation.

Products

Product Ingredients 
 
IngredientUNIICASInChI Key
Codeine hydrobromide dihydrateNot AvailableNot AvailableYYPNRUMYXOJKDO-NLMNJOOOSA-N
Codeine hydrochloride406LPJ779Q1422-07-7NUXLENPAZQNFAM-FFHNEAJVSA-N
Codeine monohydrateQ830PW75206059-47-8WRRSFOZOETZUPG-FFHNEAJVSA-N
Codeine phosphate2X585M1M3T52-28-8WUXLCJZUUHIXFY-FFHNEAJVSA-N
Codeine phosphate hemihydrateGSL05Y1MN641444-62-6DKSZLDSPXIWGFO-BLOJGBSASA-N
Codeine sulfate11QV9BS0CB6854-40-6BOLDZXRCJAJADM-AAXBYHQXSA-N
Codeine sulfate anhydrousAVW5HY4N2E1420-53-7BCXHDORHMMZBBZ-DORFAMGDSA-N
Product Images
International/Other BrandsActacode (Sigma) / Bisoltus (Boehringer Ingelheim) / Bromophar (Qualiphar) / Bronchicum (Sanofi-Aventis) / Bronchodine (Pharmacobel) / Codant (Antigen) / Codedrill (Pierre Fabre) / Codein (Cristália) / Codeisan (Belmac) / Coderpina (Frycia Centro América) / Codicalm (Welti) / Codicept / Codinex (Pinewood) / Coducept / Cougel (Hwang’s) / Coutan (Mey See) / Dinco (Center) / Farmacod (Farmacom) / Galcodine (Thornton & Ross) / Pectoral (Siphat) / Tussoret (MaxMedic)
Brand Name Prescription Products
Generic Prescription Products
Over the Counter Products
Mixture Products
Unapproved/Other Products 
 

Categories

Chemical TaxonomyProvided by Classyfire
DescriptionThis compound belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic.
Sub ClassNot Available
Direct ParentMorphinans
SubstituentsAlcohol / Alkyl aryl ether / Amine / Anisole / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Coumaran / Ether
 
 show 15 more
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptorsmorphinane alkaloid, organic heteropentacyclic compound (CHEBI:16714Isoquinoline alkaloids (C06174)
Affected organisms
  • Humans and other mammals

Chemical Identifiers

CAS number76-57-3
InChI KeyOROGSEYTTFOCAN-DNJOTXNNSA-N
InChI
InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1
IUPAC Name
(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-ol
SMILES
[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC

References

Synthesis Reference

Nagaraj R. Ayyangar, Anil R. Choudhary, Uttam R. Kalkote, Vasant K. Sharma, “Process for the preparation of codeine from morphine.” U.S. Patent US4764615, issued May, 1912.

US4764615
General References
  1. Schroeder K, Fahey T: Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001831. [Article]
  2. Vree TB, van Dongen RT, Koopman-Kimenai PM: Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract. 2000 Jul-Aug;54(6):395-8. [Article]
  3. Srinivasan V, Wielbo D, Tebbett IR: Analgesic effects of codeine-6-glucuronide after intravenous administration. Eur J Pain. 1997;1(3):185-90. [Article]
  4. Bhandari M, Bhandari A, Bhandari A: Recent updates on codeine. Pharm Methods. 2011 Jan;2(1):3-8. doi: 10.4103/2229-4708.81082. [Article]
  5. Chen ZR, Somogyi AA, Reynolds G, Bochner F: Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br J Clin Pharmacol. 1991 Apr;31(4):381-90. [Article]
  6. Takahama K, Wakuda I, Fukushima H, Isohama Y, Kai H, Miyata T: Differential effect of codeine on coughs caused by mechanical stimulation of two different sites in the airway of guinea pigs. Eur J Pharmacol. 1997 Jun 18;329(1):93-7. [Article]
  7. Straube C, Derry S, Jackson KC, Wiffen PJ, Bell RF, Strassels S, Straube S: Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006601. doi: 10.1002/14651858.CD006601.pub4. [Article]
  8. Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A: Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994-6004. doi: 10.2174/138161212803582469. [Article]
  9. Prommer E: Role of codeine in palliative care. J Opioid Manag. 2011 Sep-Oct;7(5):401-6. [Article]
  10. Lotsch J: Opioid metabolites. J Pain Symptom Manage. 2005 May;29(5 Suppl):S10-24. doi: 10.1016/j.jpainsymman.2005.01.004. [Article]
  11. Al-Hasani R, Bruchas MR: Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011 Dec;115(6):1363-81. doi: 10.1097/ALN.0b013e318238bba6. [Article]
  12. Pan HL, Wu ZZ, Zhou HY, Chen SR, Zhang HM, Li DP: Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther. 2008 Jan;117(1):141-61. doi: 10.1016/j.pharmthera.2007.09.003. Epub 2007 Sep 22. [Article]
  13. Codeine phosphate tablets, 30mg [Link]
  14. DailyMed: Codeine and promethazine syrup [Link]
  15. Codittusin, DailyMed [Link]
  16. FDA Approved Drug Products: CODEINE SULFATE tablets, for oral use CII (Jan 2024) [Link]
  17. FDA Approved Drug Products: Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII (Jan 2024) [Link]
  18. EPAR, Codeine [File]
  19. Codeine, MedSafe NZ document [File]
External Links
Human Metabolome DatabaseHMDB0004995
KEGG DrugD03580
KEGG CompoundC06174
PubChem Compound5284371
PubChem Substance46507764
ChemSpider4447447
BindingDB50105098
RxNav1545976
ChEBI16714
ChEMBLCHEMBL485
Therapeutic Targets DatabaseDAP000213
PharmGKBPA449088
WikipediaCodeine
FDA label
Download (138 KB)
MSDS
Download (52.5 KB)

Clinical Trials

Clinical Trials
 
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more.Preview package
 

Pharmacoeconomics

Manufacturers
  • Roxane laboratories inc
Packagers
  • Actavis Group
  • Aidarex Pharmacuticals LLC
  • Amarin Pharmaceuticals
  • Amerisource Health Services Corp.
  • Amneal Pharmaceuticals
  • Apotheca Inc.
  • A-S Medication Solutions LLC
  • Athlon Pharmaceuticals Inc.
  • Barr Pharmaceuticals
  • BASF Corp.
  • Blansett Pharmacal Co. Inc.
  • Blenheim Pharmacal
  • Breckenridge Pharmaceuticals
  • Bryant Ranch Prepack
  • C.O. Truxton Inc.
  • Cardinal Health
  • Carlisle Laboratories Inc.
  • Centurion Labs
  • Century Pharmaceuticals Inc.
  • Cerovene Inc.
  • Comprehensive Consultant Services Inc.
  • Corepharma LLC
  • Coupler Enterprises Inc.
  • D.M. Graham Laboratories Inc.
  • DAVA Pharmaceuticals
  • Direct Dispensing Inc.
  • Dispensing Solutions
  • Diversified Healthcare Services Inc.
  • Duramed
  • Eon Labs
  • Glenmark Generics Ltd.
  • Golden State Medical Supply Inc.
  • Great Southern Laboratories
  • H and H Laboratories
  • H.J. Harkins Co. Inc.
  • Heartland Repack Services LLC
  • Hi Tech Pharmacal Co. Inc.
  • Hospira Inc.
  • Innoviant Pharmacy Inc.
  • Ivax Pharmaceuticals
  • Janssen-Ortho Inc.
  • Jerome Stevens Pharmaceuticals Inc.
  • Kaiser Foundation Hospital
  • Keltman Pharmaceuticals Inc.
  • Lake Erie Medical and Surgical Supply
  • Lannett Co. Inc.
  • Lehigh Valley Technologies Inc.
  • Liberty Pharmaceuticals
  • Major Pharmaceuticals
  • Mallinckrodt Inc.
  • Mckesson Corp.
  • MCR American Pharmaceuticals Inc.
  • Medvantx Inc.
  • Mikart Inc.
  • Murfreesboro Pharmaceutical Nursing Supply
  • Mutual Pharmaceutical Co.
  • Nexgen Pharma Inc.
  • Novartis AG
  • Nucare Pharmaceuticals Inc.
  • Ortho-McNeil-Janssen Pharmaceuticals Inc.
  • Palmetto Pharmaceuticals Inc.
  • Patient First Corp.
  • PCA LLC
  • PD-Rx Pharmaceuticals Inc.
  • Pharmaceutical Association
  • Pharmedix
  • Pharmpak Inc.
  • Physicians Total Care Inc.
  • Poly Pharmaceuticals Inc.
  • Preferred Pharmaceuticals Inc.
  • Prepackage Specialists
  • Prepak Systems Inc.
  • Qualitest
  • Ranbaxy Laboratories
  • Rebel Distributors Corp.
  • Redpharm Drug
  • Remedy Repack
  • Roxane Labs
  • Sandhills Packaging Inc.
  • SJ Pharmaceuticals LLC
  • Southwood Pharmaceuticals
  • St Mary’s Medical Park Pharmacy
  • Stanley Pharmaceuticals Ltd.
  • Stat Rx Usa
  • Talbert Medical Management Corp.
  • Teva Pharmaceutical Industries Ltd.
  • TG United Inc.
  • UDL Laboratories
  • United Research Laboratories Inc.
  • Va Cmop Dallas
  • Valeant Ltd.
  • Vascondor Inc.
  • Veratex Corp.
  • Vintage Pharmaceuticals Inc.
  • Watson Pharmaceuticals
  • West-Ward Pharmaceuticals
  • Wockhardt Ltd.
Dosage Forms
Prices
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents

Properties

StateSolid
Experimental Properties
PropertyValueSource
melting point (°C)154-156MSDS
boiling point (°C)250http://www.chm.bris.ac.uk/webprojects2002/winder/information.htm
water solubilitysoluble in waterhttp://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con126132.pdf
logP1.39https://www.agilent.com/cs/library/applications/5990-9625EN.pdf
logS-1.52ADMET & DMPK 1(4) (2013) 48-62; doi: 10.5599/admet.1.4.24
pKa8.2http://www.inchem.org/documents/pims/pharm/codeine.htm
Predicted Properties
PropertyValueSource
Water Solubility0.577 mg/mLALOGPS
logP1.2ALOGPS
logP1.34Chemaxon
logS-2.7ALOGPS
pKa (Strongest Acidic)13.78Chemaxon
pKa (Strongest Basic)9.19Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area41.93 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity84.6 m3·mol-1Chemaxon
Polarizability31.95 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber’s RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9966
Blood Brain Barrier+0.9979
Caco-2 permeable+0.8867
P-glycoprotein substrateSubstrate0.8631
P-glycoprotein inhibitor IInhibitor0.5435
P-glycoprotein inhibitor IINon-inhibitor0.8724
Renal organic cation transporterInhibitor0.638
CYP450 2C9 substrateNon-substrate0.7698
CYP450 2D6 substrateSubstrate0.9274
CYP450 3A4 substrateSubstrate0.7796
CYP450 1A2 substrateNon-inhibitor0.6494
CYP450 2C9 inhibitorNon-inhibitor0.8866
CYP450 2D6 inhibitorInhibitor0.6978
CYP450 2C19 inhibitorNon-inhibitor0.8256
CYP450 3A4 inhibitorNon-inhibitor0.8899
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.747
Ames testNon AMES toxic0.9133
CarcinogenicityNon-carcinogens0.9567
BiodegradationNot ready biodegradable0.9935
Rat acute toxicity2.8450 LD50, mol/kgNot applicable
hERG inhibition (predictor I)Weak inhibitor0.8556
hERG inhibition (predictor II)Non-inhibitor0.8615
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum – GC-MSPredicted GC-MSsplash10-00lr-3090000000-38668348c3e45e16a9e7
Mass Spectrum (Electron Ionization)MSsplash10-01ot-3950000000-e80ecb11646b4da6aa92
LC-MS/MS Spectrum – LC-ESI-ITFT (LTQ Orbitrap XL Thermo Scientific) 60V, PositiveLC-MS/MSsplash10-0uxr-0973000000-87d07ddd2ed24b9598d7
LC-MS/MS Spectrum – LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0009000000-d68b67071bf467a42afa
LC-MS/MS Spectrum – LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0009000000-a298cedb776a11677cf7
LC-MS/MS Spectrum – LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0459000000-1a92521b38ba51a7fa81
LC-MS/MS Spectrum – LC-ESI-QTOF , positiveLC-MS/MSsplash10-0gc1-0940000000-68cae285315cfe9c7d0e
LC-MS/MS Spectrum – LC-ESI-QTOF , positiveLC-MS/MSsplash10-0uxs-0910000000-b0c288c76c616e1a54d3
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0159-0390000000-ac30542a576060b3373c
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0009000000-870de7833257cd342810
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0009000000-8ece718ed46e5e439112
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0139000000-7880499a47dbd2f41229
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0uxr-0973000000-87d07ddd2ed24b9598d7
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-015a-0920000000-4f676c9e2b42320493af
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0uxr-0910000000-e67964930533268605cd
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0009000000-99b083bf48ae39e3cec6
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0009000000-efebfbff05a4cb72fe32
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0139000000-be0f9b6eaa028b54ad6c
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0uxr-0973000000-89bc81638a52beefd890
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-015a-0920000000-7eccc8e19d8d88b18128
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0uxr-0910000000-5809a9ed32210bcfa231
LC-MS/MS Spectrum – LC-ESI-ITFT , positiveLC-MS/MSsplash10-0159-0390000000-a7469c01c0a4ff4179bf
LC-MS/MS Spectrum – LC-ESI-QQ , positiveLC-MS/MSsplash10-0uyi-1952000000-3db61b1a0c8cde5b8c82
LC-MS/MS Spectrum – LC-ESI-QQ , positiveLC-MS/MSsplash10-0lea-1940000000-b491506c23f09adaee8c
LC-MS/MS Spectrum – LC-ESI-QQ , positiveLC-MS/MSsplash10-0lea-1930000000-48dcc53ac80bf97d1f2d
Predicted MS/MS Spectrum – 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-0019000000-43c94fe9b728ab029a04
Predicted MS/MS Spectrum – 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-0069000000-8aeb7e787640fef4df6c
Predicted MS/MS Spectrum – 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0090000000-81e646137f862ed833e3
Predicted MS/MS Spectrum – 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-0191000000-aa0cc448145b0a2187e1
Predicted MS/MS Spectrum – 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0090000000-ed5f70501fbf3b0db16a
Predicted MS/MS Spectrum – 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0fu2-0090000000-c940b27cda2c20e032c2
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-174.847793
predicted
DarkChem Lite v0.1.0
[M-H]-175.160093
predicted
DarkChem Lite v0.1.0
[M-H]-174.739793
predicted
DarkChem Lite v0.1.0
[M-H]-174.61856
predicted
DeepCCS 1.0 (2019)
[M+H]+174.899893
predicted
DarkChem Lite v0.1.0
[M+H]+175.225793
predicted
DarkChem Lite v0.1.0
[M+H]+175.147793
predicted
DarkChem Lite v0.1.0
[M+H]+177.01411
predicted
DeepCCS 1.0 (2019)
[M+Na]+174.999293
predicted
DarkChem Lite v0.1.0
[M+Na]+175.306393
predicted
DarkChem Lite v0.1.0
[M+Na]+175.051793
predicted
DarkChem Lite v0.1.0
[M+Na]+184.3921
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
 
KindProtein
OrganismHumans
Pharmacological action
Yes
Actions
Agonist
Regulator
General FunctionReceptor for endogenous opioids such as beta-endorphin and endomorphin (PubMed:10529478, PubMed:12589820, PubMed:7891175, PubMed:7905839, PubMed:7957926, PubMed:9689128). Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone (PubMed:10529478, PubMed:10836142, PubMed:12589820, PubMed:19300905, PubMed:7891175, PubMed:7905839, PubMed:7957926, PubMed:9689128). Also activated by enkephalin peptides, such as Met-enkephalin or Met-enkephalin-Arg-Phe, with higher affinity for Met-enkephalin-Arg-Phe (By similarity). Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors (PubMed:7905839). The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15 (PubMed:12068084). They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B (By similarity). Also couples to adenylate cyclase stimulatory G alpha proteins (By similarity). The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4 (By similarity). Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization (By similarity). Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction (By similarity). The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins (By similarity). The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation (By similarity). Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling (By similarity). Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling (By similarity). Endogenous ligands induce rapid desensitization, endocytosis and recycling (By similarity). Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties (By similarity)
Specific Functionbeta-endorphin receptor activity
Gene NameOPRM1
Uniprot IDP35372
Uniprot NameMu-type opioid receptor
Molecular Weight44778.855 Da
References
  1. Takahama K, Shirasaki T: Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs. Cough. 2007 Jul 9;3:8. [Article]
  2. Raffa RB: A novel approach to the pharmacology of analgesics. Am J Med. 1996 Jul 31;101(1A):40S-46S. doi: 10.1016/s0002-9343(96)00137-4. [Article]
  3. Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier MC, Deprez B: From hit to lead. Combining two complementary methods for focused library design. Application to mu opiate ligands. J Med Chem. 2001 Oct 11;44(21):3378-90. [Article]
  4. Liu T, Hwang L, Burley SK, Nitsche CI, Southan C, Walters WP, Gilson MK: BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data. Nucleic Acids Res. 2025 Jan 6;53(D1):D1633-D1644. doi: 10.1093/nar/gkae1075. [Article]
  5. Codeine FDA label [File]
  6. EPAR, Codeine [File]
KindProtein
OrganismHumans
Pharmacological action
Yes
Actions
Agonist
Curator commentsThis target action is based on in vitro data.
General FunctionG-protein coupled opioid receptor that functions as a receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as a receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions
Specific Functiondynorphin receptor activity
Gene NameOPRK1
Uniprot IDP41145
Uniprot NameKappa-type opioid receptor
Molecular Weight42644.665 Da
References
  1. Mignat C, Wille U, Ziegler A: Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 1995;56(10):793-9. [Article]
  2. Schmidt H, Vormfelde Sv, Klinder K, Gundert-Remy U, Gleiter CH, Skopp G, Aderjan R, Fuhr U: Affinities of dihydrocodeine and its metabolites to opioid receptors. Pharmacol Toxicol. 2002 Aug;91(2):57-63. [Article]
KindProtein
OrganismHumans
Pharmacological action
Yes
Actions
Agonist
General FunctionG-protein coupled receptor that functions as a receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine
Specific FunctionG protein-coupled enkephalin receptor activity
Gene NameOPRD1
Uniprot IDP41143
Uniprot NameDelta-type opioid receptor
Molecular Weight40368.235 Da
References
  1. Mignat C, Wille U, Ziegler A: Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 1995;56(10):793-9. [Article]
  2. Schmidt H, Vormfelde Sv, Klinder K, Gundert-Remy U, Gleiter CH, Skopp G, Aderjan R, Fuhr U: Affinities of dihydrocodeine and its metabolites to opioid receptors. Pharmacol Toxicol. 2002 Aug;91(2):57-63. [Article]
  3. Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751. [Article]
  4. Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier MC, Deprez B: From hit to lead. Combining two complementary methods for focused library design. Application to mu opiate ligands. J Med Chem. 2001 Oct 11;44(21):3378-90. [Article]
  5. Liu T, Hwang L, Burley SK, Nitsche CI, Southan C, Walters WP, Gilson MK: BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data. Nucleic Acids Res. 2025 Jan 6;53(D1):D1633-D1644. doi: 10.1093/nar/gkae1075. [Article]
  6. ChemBL resource, opioid receptors [Link]

Enzymes

KindProtein
OrganismHumans
Pharmacological action
Unknown
Actions
Substrate
General FunctionA cytochrome P450 monooxygenase involved in the metabolism of fatty acids, steroids and retinoids (PubMed:18698000, PubMed:19965576, PubMed:20972997, PubMed:21289075, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH–hemoprotein reductase) (PubMed:18698000, PubMed:19965576, PubMed:20972997, PubMed:21289075, PubMed:21576599). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA) (PubMed:19965576, PubMed:20972997). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 20-hydroxyeicosatetraenoic acid ethanolamide (20-HETE-EA) and 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:18698000, PubMed:21289075). Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis (PubMed:21576599). Catalyzes the oxidative transformations of all-trans retinol to all-trans retinal, a precursor for the active form all-trans-retinoic acid (PubMed:10681376). Also involved in the oxidative metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants
Specific Functionanandamide 11,12 epoxidase activity
Gene NameCYP2D6
Uniprot IDP10635
Uniprot NameCytochrome P450 2D6
Molecular Weight55768.94 Da
References
  1. Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. [Article]
  2. Yue QY, Sawe J: Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes. Eur J Clin Pharmacol. 1997;52(1):41-7. [Article]
  3. Flockhart Table of Drug Interactions [Link]
  4. Codeine FDA label [File]
KindProtein
OrganismHumans
Pharmacological action
Unknown
Actions
Substrate
General FunctionA cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH–hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:21490593, PubMed:21576599, PubMed:2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed:11555828, PubMed:12865317, PubMed:14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed:15373842, PubMed:15764715, PubMed:22773874, PubMed:2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed:15373842, PubMed:15764715, PubMed:2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed:21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed:9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed:19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed:10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed:11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed:11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed:10759686). Hydroxylates antimalarial drug quinine (PubMed:8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed:29461981)
Specific Function1,8-cineole 2-exo-monooxygenase activity
Gene NameCYP3A4
Uniprot IDP08684
Uniprot NameCytochrome P450 3A4
Molecular Weight57342.67 Da
References
  1. Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE: Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos. 2004 Nov;32(11):1201-8. doi: 10.1124/dmd.104.000794. Epub 2004 Aug 10. [Article]
  2. Yue QY, Sawe J: Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes. Eur J Clin Pharmacol. 1997;52(1):41-7. [Article]
  3. Codeine FDA label [File]
KindProtein
OrganismHumans
Pharmacological action
Unknown
Actions
Substrate
General FunctionUDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite’s water solubility, thereby facilitating excretion into either the urine or bile (PubMed:10702251, PubMed:15470161, PubMed:15472229, PubMed:17442341, PubMed:18674515, PubMed:18719240, PubMed:19022937, PubMed:23288867, PubMed:23756265, PubMed:26220143, PubMed:15231852, PubMed:21422672, PubMed:38211441). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:15470161, PubMed:18674515, PubMed:23756265). Catalyzes the glucuronidation of endogenous steroid hormones such as androgens (epitestosterone, androsterone) and estrogens (estradiol, epiestradiol, estriol, catechol estrogens) (PubMed:15472229, PubMed:17442341, PubMed:18719240, PubMed:19022937, PubMed:2159463, PubMed:23288867, PubMed:26220143). Also regulates the levels of retinoic acid, a major metabolite of vitamin A involved in apoptosis, cellular growth and differentiation, and embryonic development (PubMed:10702251). Contributes to bile acid (BA) detoxification by catalyzing the glucuronidation of BA substrates, which are natural detergents for dietary lipids absorption (PubMed:23756265). Involved in the glucuronidation of arachidonic acid (AA) and AA-derived eicosanoids including 15-HETE, 20-HETE, PGE2, PGB1 and F2-isoprostanes (8-iso-PGF2alpha and 5-epi-5-F2t-IsoP) (PubMed:15231852, PubMed:38211441). Involved in the glucuronidation of the phytochemical ferulic acid at the phenolic or the carboxylic acid group (PubMed:21422672). Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist losartan, caderastan and zolarsatan, drugs which can inhibit the effect of angiotensin II (PubMed:18674515). Also metabolizes mycophenolate, an immunosuppressive agent (PubMed:15470161)
Specific Functionglucuronosyltransferase activity
Gene NameUGT2B7
Uniprot IDP16662
Uniprot NameUDP-glucuronosyltransferase 2B7
Molecular Weight60720.15 Da
References
  1. Coffman BL, Rios GR, King CD, Tephly TR: Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos. 1997 Jan;25(1):1-4. [Article]
  2. Raungrut P, Uchaipichat V, Elliot DJ, Janchawee B, Somogyi AA, Miners JO: In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans. J Pharmacol Exp Ther. 2010 Aug;334(2):609-18. doi: 10.1124/jpet.110.167916. Epub 2010 May 18. [Article]
  3. Codeine FDA label [File]
KindProtein
OrganismHumans
Pharmacological action
Unknown
Actions
Substrate
General FunctionUDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite’s water solubility, thereby facilitating excretion into either the urine or bile (PubMed:18719240, PubMed:23288867). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:18719240, PubMed:23288867). Catalyzes the glucuronidation of the endogenous estrogen hormones such as estradiol and estriol (PubMed:18719240, PubMed:23288867)
Specific Functionglucuronosyltransferase activity
Gene NameUGT2B4
Uniprot IDP06133
Uniprot NameUDP-glucuronosyltransferase 2B4
Molecular Weight60512.035 Da
References
  1. Raungrut P, Uchaipichat V, Elliot DJ, Janchawee B, Somogyi AA, Miners JO: In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans. J Pharmacol Exp Ther. 2010 Aug;334(2):609-18. doi: 10.1124/jpet.110.167916. Epub 2010 May 18. [Article]
  2. Gelston EA, Coller JK, Lopatko OV, James HM, Schmidt H, White JM, Somogyi AA: Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects. Br J Clin Pharmacol. 2012 May;73(5):786-94. doi: 10.1111/j.1365-2125.2011.04145.x. [Article]

Dive into the diverse world of online gaming at wantedwin casino, where you can enjoy a vast selection of slots, table games, and live dealers from top-tier software providers.